Matthew R. Henn - Chief Scientific Officer and EVP at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer and EVP
Issuer Symbol
MCRB on Nasdaq
All Insider Reports
All Insider Reports

Matthew R. Henn - trading volume in the past year for Seres Therapeutics, Inc.

Holdings reported by Matthew R. Henn for Seres Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,527 $130,217 $17.30 15 Nov 2025 Direct
Restricted Stock Units 878 $18,996 $0.8105 15 Nov 2025 Direct Common Stock
Stock Option (Right to Buy) 650,000 07 Feb 2025 Direct Common Stock

Transactions reported by Matthew R. Henn for Seres Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.